Merck , known as MSD outside of the United States and Canada, today announced that new clinical and outcomes research data will be presented at the American College of Cardiology's Annual Scientific ...
Verywell Health on MSN2d
Side Effects of Acetaminophen (Tylenol)Acetaminophen is generally a safe and effective pain reliever, but it can can lead to serious side effects and liver damage ...
February saw several changes on boards at biotechs, bringing a diverse wealth of experience to support these companies. Read ...
SeaStar Medical has been selected to receive the 2025 Corporate Innovator Award from the National Kidney Foundation (NKF) at the 2025 Spring Clinical Meetings in ...
Zacks Investment Research on MSN3d
J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's DiseaseJohnson & Johnson JNJ announced that the FDA has granted approval to its key drug, Tremfya, for its second inflammatory bowel ...
Gilead Sciences has bulked up its early-stage R&D portfolio with an agreement to buy XinThera, adding drugs targeting PARP ... including AstraZeneca and Merck & Co’s category-leading Lynparza ...
Background To compare the effectiveness and treatment persistence of ocrelizumab, cladribine and natalizumab in patients with relapsing–remitting multiple sclerosis switching from fingolimod. Methods ...
Merck KGa A officials say that, ultimately, the SMARTfacturing transformation benefits its customers, patients, and the ...
Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...
A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...
Gvoke VialDx is a concentrated liquid glucagon product. For diagnostic procedures, it works as a gastrointestinal motility inhibitor. The product is supplied as a single-dose vial containing 1mg of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback